logo
Select company
Select metric
0%Inventory to Assets Ratio
VS
Market
48
Sector
44
Industry
23
History
93
$ 57.77Close
$ 7.36 - $ 60.55 52-Week Range
Ticker Information

Ticker

NKTR

Company Name

NEKTAR THERAPEUTICS

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEKTAR THERAPEUTICS - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NKTR - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 207.53M$ 00%
3/31/2025$ 256.24M$ 00%
12/31/2024$ 303.85M$ 00%
9/30/2024$ 307.97M$ 00%
6/30/2024$ 343.33M$ 14.46M4.21%
3/31/2024$ 396.01M$ 16.24M4.1%
12/31/2023$ 398.03M$ 16.1M4.05%
9/30/2023$ 442.24M$ 15.13M3.42%
6/30/2023$ 494.28M$ 20.69M4.19%
3/31/2023$ 561.74M$ 20.23M3.6%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEKTAR THERAPEUTICS's latest trailing twelve months (TTM) Inv. to Assets stands at 0.85%.
  • Over the past 5 years, NEKTAR THERAPEUTICS's average Inv. to Assets has been 1.94%.
  • The median Inv. to Assets for NEKTAR THERAPEUTICS during this period was 1.46%
  • NEKTAR THERAPEUTICS reached its highest Inv. to Assets over the past 5 years at 4.21%.
  • The lowest Inv. to Assets recorded by NEKTAR THERAPEUTICS in the same timeframe 0%

NEKTAR THERAPEUTICS's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
YMAB : Y-MABS THERAPEUTICS INC 24.69%LXRX : LEXICON PHARMACEUTICALS INC 0.07%ADCT : ADC THERAPEUTICS SA 5.52%KURA : KURA ONCOLOGY INC 0%SAGE : SAGE THERAPEUTICS INC 0%TBPH : THERAVANCE BIOPHARMA INC 0%TRDA : ENTRADA THERAPEUTICS INC 0%XOMA : XOMA ROYALTY CORP 0%GOSS : GOSSAMER BIO INC 0%CDXS : CODEXIS INC 1.41%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for NEKTAR THERAPEUTICS is calculated as follows: Inventory [ $ 12.89M ] / Assets [ $ 1.51B ]
(=) Inv. to Assets [ 0.85% ]

NKTR - Inventory to Assets Ratio, Last 5 years

0%

Minimum

Sep 30, 2024

4.21%

Maximum

Jun 30, 2024

1.94%

Average

1.46%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.08%
median0%
std11.11%